Regulus Therapeutics (RGLS) PT Lowered to $0.50 at Wells Fargo
Tweet Send to a Friend
Wells Fargo analyst Jim Birchenough lowered his price target on Regulus Therapeutics (NASDAQ: RGLS) to $0.50 (from $1.50) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
